Ingevity included in TIME America's Best Companies 2026 list
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity included in TIME America's Best Companies 2026 list.
NGVT - Ingevity Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$82.50
DETAILS
HIGH:
$83.00
LOW:
$82.00
MEDIAN:
$82.50
CONSENSUS:
$82.50
UPSIDE:
17.40%
Stock News
NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes
Ingevity's Q2 earnings beat estimates as pricing, mix and higher volumes lifted margins, prompting higher 2026 earnings and EBITDA guidance.
Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact
Ingevity Corporation (NYSE: NGVT) today announced it has published its [url="]2025 Sustainability Report[/url] featuring the company's advanced materials and tec
Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation has published its 2025 Sustainability Report titled “A Decade of Performance, a Future of Possibility.".
Ingevity Q2 Earnings Call Highlights
Ingevity NYSE: NGVT reported second-quarter 2026 results marked by higher adjusted earnings, margin expansion and progress on its portfolio simplification efforts, as the company raised its full-year adjusted EBITDA and earnings-per-share outlook.
Bank of New York Mellon Corp Has $15.03 Million Stake in Ingevity Corporation $NGVT
Bank of New York Mellon Corp reduced its stake in shares of Ingevity Corporation (NYSE: NGVT) by 6.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 211,002 shares of the company's stock after selling 13,808 shares during the quarter.
Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
Ingevity (NGVT) Tops Q2 Earnings and Revenue Estimates
Ingevity (NGVT) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.39 per share a year ago.
Ingevity reports second quarter 2026 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity raises full year Adjusted EBITDA outlook following a solid start to the year.
NGVT's Evotherm P35 Gets German Approval for Warm-Mix Asphalt Use
Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.
Ingevity's Evotherm® P35 receives BASt approval in Germany
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Evotherm® P35 warm-mix additive has received approval from Germany's Federal Highway Research Institute, known as BASt.
Ingevity Shares Rise 25% YTD: Can the Stock Sustain the Rally?
NGVT shares are up 24.8% YTD, beating the industry, as portfolio optimization, hybrid demand and pricing actions drive earnings and boost outlook.
Ingevity CEO Dave Li and CFO Phillip Platt to speak at 2026 Wells Fargo Industrials & Materials Conference
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Dave Li, president and CEO, will speak at the 2026 Wells Fargo Industrials & Materials Conference on Thursday, June 11.
Why Is Ingevity (NGVT) Down 10.8% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Ingevity Q1 Earnings Call Highlights
Ingevity NYSE: NGVT reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance Materials business and continued share repurchases.
NGVT Q1 Earnings Top Estimates on Pricing and FX Tailwinds
Ingevity beats Q1 estimates as pricing actions and FX gains lift sales and earnings, despite weakness in Road Markings and lower asset utilization.
Ingevity Corporation (NGVT) Q1 2026 Earnings Call Transcript
Ingevity Corporation (NGVT) Q1 2026 Earnings Call Transcript
Ingevity (NGVT) Beats Q1 Earnings and Revenue Estimates
Ingevity (NGVT) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.99 per share a year ago.
Ingevity reports first quarter 2026 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)-- #ingevity--Ingevity reports first quarter 2026 financial results.
Head to Head Review: Ingevity (NYSE:NGVT) and Mativ (NYSE:MATV)
Ingevity (NYSE: NGVT - Get Free Report) and Mativ (NYSE: MATV - Get Free Report) are both basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and profitability. Insider and Institutional Ownership 91.6% of Ingevity shares are
Price Targets
Ingevity Corp (NGVT) PT Raised to $83 at BMO Capital
$83.00
(was $72.03)
John McNulty
·
BMO Capital
Ingevity Corp (NGVT) PT Raised to $82 at Jefferies
$82.00
(was $70.52)
Daniel Rizzo
·
Jefferies
Ingevity price target raised to $65 from $60 at Wells Fargo
$65.00
(was $65.26)
Wells Fargo
Ingevity price target raised to $70 from $64 at BMO Capital
$70.00
(was $56.23)
BMO Capital
Ingevity price target raised to $68 from $62 at BMO Capital
$68.00
(was $59.77)
BMO Capital
Ingevity price target raised to $62 from $56 at BMO Capital
$62.00
(was $49.69)
John McNulty
·
BMO Capital
Ingevity Corp (NGVT) PT Raised to $47 at BMO Capital
$47.00
(was $41.79)
John McNulty
·
BMO Capital
Ingevity price target lowered to $42 from $45 at BMO Capital
$42.00
(was $35.63)
John McNulty
·
BMO Capital
Ingevity price target lowered to $45 from $48 at BMO Capital
$45.00
(was $40.62)
John McNulty
·
BMO Capital
Ingevity Corp (NGVT) PT Raised to $56 at Loop Capital
$56.00
(was $53.85)
Chris Kapsch
·
Loop Capital Markets
Jefferies Upgrades Ingevity Corp (NGVT) to Buy, 'Activated Carbon Solid, Intermediate Chemicals Rebound Likely'
$62.00
(was $44.44)
Daniel Rizzo
·
Jefferies
Loop Capital Upgrades Ingevity Corp (NGVT) to Buy
$100.00
(was $87.00)
Christopher Kapsch
·
Loop Capital Markets